Recreational nitrous oxide use: Prevalence and risks

Regulatory Toxicology and Pharmacology

Volumn 73, Issue 3, 2015, Pages 790-796

  van Amsterdam, Jan ^a   Nabben, Ton ^a   van den Brink, Wim ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b AMSTERDAM INSTITUTE FOR ADDICTION RESEARCH   (Netherlands)

Author keywords

Anesthetic; Bulbs; Dependence; Laughing gas; Megaloblastoma; Nitrous oxide; Peripheral neuropathy; Recreational use; Whippits

Indexed keywords

NITROUS OXIDE; RECREATIONAL DRUG; GAS; STREET DRUG;

ACCIDENT; ARTICLE; BALANCE DISORDER; COGNITIVE DEFECT; CYANOCOBALAMIN DEFICIENCY; DISORIENTATION; DISSOCIATION; DIZZINESS; DRUG DEPENDENCE; DRUG SAFETY; HUMAN; LEG DISEASE; LEGAL ASPECT; MEGALOBLASTIC ANEMIA; MEMORY DISORDER; NONHUMAN; PERIPHERAL NEUROPATHY; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT; WEAKNESS; DOSE RESPONSE; GAS; INHALATIONAL DRUG ADMINISTRATION; MORTALITY; PREVALENCE; RISK FACTOR; SUBSTANCE-RELATED DISORDERS; TIME FACTOR;

ADMINISTRATION, INHALATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GASES; HUMANS; NITROUS OXIDE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 84952717409     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2015.10.017     Document Type: Article

References (89)

1. ACMD Advisory Council on the Misuse of Drugs (ACMD). Advice on Nitrous Oxide 2015, https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/409403/acmd-advice-on-nitrous-oxide.doc.
2. Alt R.S., Morrissey R.P., Gang M.A., Hoffman R.S., Schaumburg H.H. Severe myeloneuropathy from acute high-dose nitrous oxide (N2O) abuse. J. Emerg. Med. 2011, 41:378-380.
3. Amos R.J., Amess J.A., Hinds C.J., Mollin D.L. Incidence and pathogenesis of acute megaloblastic bone-marrow change in patients receiving intensive care. Lancet 1982, 2:835-838.
4. Armstrong P.J., Morton C., Sinclair W., Tiplady B. Effects of nitrous oxide on psychological performance. A dose-response study using inhalation of concentrations up to 15%. Psychopharmacol. Berl. 1995, 117:486-490.
5. ASA American Society of Anesthesiologists (ASA). Anesthetic Gases: Information for Management in Anesthetizing Areas and the Postanesthesia Care Unit (PACU) 1999, http://ecommerce.asahq.org/publicationsAndServices/wasteanes.pdf.
6. Bar-Meir E., Zaslansky R., Regev E., Keidan I., Orenstein A., Winkler E. Nitrous oxide administered by the plastic surgeon for repair of facial lacerations in children in the emergency room. Plast. Reconstr. Surg. 2006, 117:1571-1575.
7. Benschop A., Nabben T., Korf D.J. Antenne 2012. Trends in alcohol, tabak en drugs bij jonge Amsterdammers 2013, Rozenberg Publishers, Amsterdam. https://www.jellinek.nl/wp-content/uploads/2013/06/Antenne-2012.pdf.
8. Blanton A. Nitrous oxide abuse: dentistry's unique addiction. J. Tenn. Dent. Assoc. 2006, 86:30-31.
9. Block R.I., Ghoneim M.M., Pathak D., Kumar V., Hinrichs J.V. Effects of a subanesthetic concentration of nitrous oxide on overt and covert assessments of memory and associative processes. Psychopharmacol. Berl. 1988, 96:324-331.
10. Brett A. Myeloneuropathy from whipped cream bulbs presenting as conversion disorder. Aust. N. Z. J. Psychiatry 1997, 31:131-132.
11. Brodsky J.B., Cohen E.N., Brown B.W., Wu M.L., Whitcher C.E. Exposure to nitrous oxide and neurologic disease among dental professionals. Anesth. Analg. 1981, 60:297-301.
12. Butzkueven H., King J.O. Nitrous oxide myelopathy in an abuser of whipped cream bulbs. J. Clin. Neurosci. 2000, 7:73-75.
13. Cartner M., Sinnott M., Silburn P. Paralysis caused by "nagging". Med. J. Aust. 2007, 187:366-367.
14. Cheng H.M., Park J.H., Hernstadt D. Subacute combined degeneration of the spinal cord following recreational nitrous oxide use. BMJ Case Rep. 2013, 2013.
15. Cockery J., Loi B., Goodair C., Schifano F. Drug Related Deaths in the UK: Jan-Dec 2012-2013 2014.
16. Cockery J., Schifano F. Volatile Substance Abuse Mortality Project 2015, http://researchprofiles.herts.ac.uk/portal/en/projects/volatile-substance-abuse-mortality-project%252868e81f06-a692-47d3-a9c3-96b5a93ce34f%2529.html.
17. Collins M. A case report on the anxiolytic properties of nitrous oxide during labor. J. Obstet. Gynecol. Neonatal Nurs. 2015, 44:87-92.
18. Daynes G., Gillman M.A. Psychotropic analgesic nitrous oxide prevents craving after withdrawal for alcohol, cannabis and tobacco. Int. J. Neurosci. 1994, 76:13-16.
19. Diamond A.L., Diamond R., Freedman S.M., Thomas F.P. "Whippets"-induced cobalamin deficiency manifesting as cervical myelopathy. J. Neuroimaging 2004, 14:277-280.
20. Dohrn C.S., Lichtor J.L., Finn R.S., Uitvlugt A., Coalson D.W., Rupani G., de W.H., Zacny J.P. Subjective and psychomotor effects of nitrous oxide in healthy volunteers. Behav. Pharmacol. 1992, 3:19-30.
21. Duarte R., McNeill A., Drummond G., Tiplady B. Comparison of the sedative, cognitive, and analgesic effects of nitrous oxide, sevoflurane, and ethanol. Br. J. Anaesth. 2008, 100:203-210.
22. Fink B.R., Shepard T.H., Blandau R.J. Teratogenic activity of nitrous oxide. Nature 1967, 214:146-148.
23. Garakani A., Welch A.K., Jaffe R.J., Protin C.A., McDowell D.M. Psychosis and low cyanocobalamin in a patient abusing nitrous oxide and cannabis. Psychosomatics 2014, 55:715-719.
24. Garland E.L., Howard M.O., Perron B.E. Nitrous oxide inhalation among adolescents: prevalence, correlates, and co-occurrence with volatile solvent inhalation. J. Psychoact. Drugs 2009, 41:337-347.
25. GDS The Global Drug Survey (GDS) 2014 Findings. Last 12 Month Prevalence of Top 20 Drugs 2015, http://www.globaldrugsurvey.com/wp-content/uploads/2014/04/last-12-months-drug-prevalence.pdf.
26. Ghoneim M.M., Mewaldt S.P., Peterson R.C. Subanesthetic concentration of nitrous oxide and human memory. Prog. Neuro Psychopharmacol. 1981, 5:395-402.
27. Gillman M.A. Nitrous oxide abuse in perspective. Clin. Neuropharmacol. 1992, 15:297-306.
28. Gillman M.A., Lichtigfeld F.J. Analgesic nitrous oxide: adjunct to clonidine for opioid withdrawal. Am. J. Psychiatry 1985, 142:784-785.
29. Gillman M.A., Lichtigfeld F.J., Harker N. Psychotropic analgesic nitrous oxide for acute cocaine withdrawal in man. Int. J. Neurosci. 2006, 116:847-857.
30. Gillman M.A., Lichtigfeld F.J., Young T.N. Psychotropic analgesic nitrous oxide for alcoholic withdrawal states. Cochrane Database Syst. Rev. 2007, CD005190.
31. Goossens F.X., Frijns T., Hasselt N.E., van Laar M.W. Het grote uitgaansonderzoek 2013. Uitgaanspatronen, middelengebruik en risicogedrag onder uitgaande jongeren en jongvolwassenen 2014, Trimbos-instituut, Utrecht.
32. Home Office Drug Misuse: Findings from the 2013/14 Crime Survey for England and Wales 2014, Government, ONS; 2014 15/08/2014]. http://www.gov.uk.
33. Hsu C.K., Chen Y.Q., Lung V.Z., His S.C., Lo H.C., Shyu H.Y. Myelopathy and polyneuropathy caused by nitrous oxide toxicity: a case report. Am. J. Emerg. Med. 2012, 30:1016.
34. Imberger G., Orr A., Thorlund K., Wetterslev J., Myles P., Moller A.M. Does anaesthesia with nitrous oxide affect mortality or cardiovascular morbidity? A systematic review with meta-analysis and trial sequential analysis. Br. J. Anaesth. 2014, 112:410-426.
35. Jakovljevic M., Vidmar G., Mekjavic I.B. Psychomotor function during mild narcosis induced by subanesthetic level of nitrous oxide: individual susceptibility beyond gender effect. Undersea Hyperb. Med. 2012, 39:1067-1074.
36. Jay M. Nitrous oxide: recreational use, regulation and harm reduction. Drugs Alcohol Today 2008, 8:22-25.
37. Jevtovic-Todorovic V., Todorovic S.M., Mennerick S., Powell S., Dikranian K., Benshoff N., Zorumski C.F., Olney J.W. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat. Med. 1998, 4:460-463.
38. Lassen H.C., Henriksen E., Neukirch F., Kristensen H.S. Treatment of tetanus; severe bone-marrow depression after prolonged nitrous-oxide anaesthesia. Lancet 1956, 270:527-530.
39. Leslie K., Myles P.S., Chan M.T., Forbes A., Paech M.J., Peyton P., Silbert B.S., Williamson E. Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial. Anesth. Analg. 2011, 112:387-393.
40. Likis F.E., Andrews J.C., Collins M.R., Lewis R.M., Seroogy J.J., Starr S.A., Walden R.R., McPheeters M.L. Nitrous oxide for the management of labor pain: a systematic review. Anesth. Analg. 2014, 118:153-167.
41. Lin R.J., Chen H.F., Chang Y.C., Su J.J. Subacute combined degeneration caused by nitrous oxide intoxication: case reports. Acta Neurol. Taiwan 2011, 20:129-137.
42. Maze M., Fujinaga M. Pharmacology of nitrous oxide. Best. Pract. Res. Clin. Anaesthesiol. 2001, 15:339-348.
43. Mewaldt S.P., Ghoneim M.M., Choi W.W., Korttila K., Peterson R.C. Nitrous oxide and human state-dependent memory. Pharmacol. Biochem. Behav. 1988, 30:83-87.
44. Miller M.A., Martinez V., McCarthy R., Patel M.M. Nitrous oxide "whippit" abuse presenting as clinical B12 deficiency and ataxia. Am. J. Emerg. Med. 2004, 22:124.
45. Moyes D., Cleaton-Jones P., Lelliot J. Evaluation of driving skills after brief exposure to nitrous oxide. S. Afr. Med. J. 1979, 56:1000-1002.
46. Nabben T., Benschop A., Korf D.J. ANTENNE 2013, trends in alcohol, tabak en drugs bij jonge Amsterdammers 2014, Rozenberg, Amsterdam.
47. Nagele P., Duma A., Kopec M., Gebara M.A., Parsoei A., Walker M., Janski A., Panagopoulos V.N., Cristancho P., Miller J.P., Zorumski C.F., Conway C.R. Nitrous oxide for treatment-resistant major depression: a proof-of-concept trial. Biol. Psychiatry 2015, 78:10-18.
48. Ng J., O'Grady G., Pettit T., Frith R. Nitrous oxide use in first-year students at Auckland University. Lancet 2003, 361:1349-1350.
49. Nunn J.F. Clinical aspects of the interaction between nitrous oxide and vitamin B12. Br. J. Anaesth. 1987, 59:3-13.
50. Nunn J.F., Chanarin I., Tanner A.G., Owen E.R. Megaloblastic bone marrow changes after repeated nitrous oxide anaesthesia. Reversal with folinic acid. Br. J. Anaesth. 1986, 58:1469-1470.
51. O'Donovan M.R., Hammond T.G. Is nitrous oxide a genotoxic carcinogen?. Mutagenesis 2015, 30:459-462.
52. OAS Office of Applied Studies (OAS). The NSDUH Report: Trends in Adolescent Inhalant Use: 2002 to 2007 2009.
53. Ohashi Y., Guo T., Orii R., Maze M., Fujinaga M. Brain stem opioidergic and GABAergic neurons mediate the antinociceptive effect of nitrous oxide in Fischer rats. Anesthesiology 2003, 99:947-954.
54. Ohryn M. Tympanic membrane rupture following general anesthesia with nitrous oxide: a case report. AANA J. 1995, 63:42-44.
55. Owens W.D., Gustave F., Sclaroff A. Tympanic membrane rupture with nitrous oxide anesthesia. Anesth. Analg. 1978, 57:283-286.
56. Perreault L., Normandin N., Plamondon L., Blain R., Rousseau P., Girard M., Forget G. Tympanic membrane rupture after anesthesia with nitrous oxide. Anesthesiology 1982, 57:325-326.
57. Poorsattar S.P. Recognizing and managing dental fears: anxiolysis from the perspective of a dental student. J. Dent. Educ. 2010, 74:397-401.
58. Probasco J.C., Felling R.J., Carson J.T., Dorsey E.R., Niessen T.M. Teaching NeuroImages: myelopathy due to B(1)(2) deficiency in long-term colchicine treatment and nitrous oxide misuse. Neurology 2011, 77:e51.
59. Ramsay D.S., Watson C.H., Leroux B.G., Prall C.W., Kaiyala K.J. Conditioned place aversion and self-administration of nitrous oxide in rats. Pharmacol. Biochem. Behav. 2003, 74:623-633.
60. Richardson K.J., Shelton K.L. N-methyl-D-aspartate receptor channel blocker-like discriminative stimulus effects of nitrous oxide gas. J. Pharmacol. Exp. Ther. 2015, 352:156-165.
61. Richardson P.G. Peripheral neuropathy following nitrous oxide abuse. Emerg. Med. Australas. 2010, 22:88-90.
62. Rooks J.P. Safety and risks of nitrous oxide labor analgesia: a review. J. Midwifery Womens Health 2011, 56:557-565.
63. Rosenberg H., Orkin F.K., Springstead J. Abuse of nitrous oxide. Anesth. Analg. 2015, 58:104-106.
64. Royston B.D., Nunn J.F., Weinbren H.K., Royston D., Cormack R.S. Rate of inactivation of human and rodent hepatic methionine synthase by nitrous oxide. Anesthesiology 1988, 68:213-216.
65. Sahenk Z., Mendell J.R., Couri D., Nachtman J. Polyneuropathy from inhalation of N2O cartridges through a whipped-cream dispenser. Neurology 1978, 28:485-487.
66. SAMHSA Substance Abuse and Mental Health Services Administration (SAMHSA). National Survey on Drug Use and Health 2013, https://www.icpsr.umich.edu/icpsrweb/SAMHDA/ssvd/studies/35509/datasets/0001/variables/NITOXID?q%3DNITOXID%26series%3DNational%2BSurvey%2Bon%2BDrug%2BUse%2Band%2BHealth%2B%2528NSDUH%2529%2BSeries%26paging.startRow%3D26.
67. Sanders R.D., Ma D., Maze M. Anaesthesia induced neuroprotection. Best. Pract. Res. Clin. Anaesthesiol. 2005, 19:461-474.
68. Sanders R.D., Weimann J., Maze M. Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology 2008, 109:707-722.
69. Schallner N., Goebel U. The perioperative use of nitrous oxide: renaissance of an old gas or funeral of an ancient relict?. Curr. Opin. Anaesthesiol. 2013, 26:354-360.
70. Sethi N.K., Mullin P., Torgovnick J., Capasso G. Nitrous oxide "whippit" abuse presenting with cobalamin responsive psychosis. J. Med. Toxicol. 2006, 2:71-74.
71. Sindicich N., Burns L. Australian Trends in Ecstasy and Related Drug Markets 2013. Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Australian Drug Trends Series No. 118 2014, National Drug and Alcohol Research Centre, UNSW Australia, Sydney. https://ndarc.med.unsw.edu.au/resource/ecstasy-and-related-drugs-reporting-system-edrs-national-report-2013.
72. Stacy C.B., Di R.A., Gould R.J. Methionine in the treatment of nitrous-oxide-induced neuropathy and myeloneuropathy. J. Neurol. 1992, 239:401-403.
73. Sund K.H., Berthelsen P.G. Risus sardonicus and laughing gas-when nitrous oxide lost its innocence. Acta Anaesthesiol. Scand. 1994, 38:751-752.
74. Suruda A.J., McGlothlin J.D. Fatal abuse of nitrous oxide in the workplace. J. Occup. Med. 1990, 32:682-684.
75. Thompson A.G., Leite M.I., Lunn M.P., Bennett D.L. Whippits, nitrous oxide and the dangers of legal highs. Pract. Neurol. 2015, 15:207-209.
76. Vaisman A.I. Working conditions in the operating room and their effect on the health of anesthetists. Eksp. Khir. Anesteziol. 1967, 12:44-49.
77. Wagner S.A., Clark M.A., Wesche D.L., Doedens D.J., Lloyd A.W. Asphyxial deaths from the recreational use of nitrous oxide. J. Forensic Sci. 1992, 37:1008-1015.
78. Walker D.J., Zacny J.P. Within- and between-subject variability in the reinforcing and subjective effects of nitrous oxide in healthy volunteers. Drug Alcohol Depend. 2001, 64:85-96.
79. Walker D.J., Zacny J.P. Analysis of the reinforcing and subjective effects of different doses of nitrous oxide using a free-choice procedure. Drug Alcohol Depend. 2002, 66:93-103.
80. Walker D.J., Zacny J.P. Bitonic dose-response functions for reinforcing and self-reported effects of nitrous oxide in humans. Pharmacol. Biochem. Behav. 2003, 74:851-857.
81. Winek C.L., Wahba W.W., Rozin L. Accidental death by nitrous oxide inhalation. Forensic Sci. Int. 1995, 73:139-141.
82. Winstock A., Ferris J., Kaar S. GDS 2015 Findings. Data about Nitrous Oxide Presented by A.R. Winstock on YouTube 2015, https://www.youtube.com/watch?v=T1i0a1onUhY.
83. Winstock A.R. The Global Drug Survey 2015 Findings. What Did We Learn from GDS2015? An Overview of Our Key Findings 2015, http://www.globaldrugsurvey.com/the-global-drug-survey-2015-findings/.
84. Wong S.L., Harrison R., Mattman A., Hsiung G.Y. Nitrous oxide (N2O)-induced acute psychosis. Can. J. Neurol. Sci. 2014, 41:672-674.
85. Wood D.M., Measham F., Dargan P.I. Pattern of nitrous oxide use in a men who have sex with men, high-drug using population: how does this compare to the 2011/2012 Global Drug Survey? 2013 Annual Meeting of the North American Congress of Clinical Toxicology (NACCT). Clin. Toxicol. Phila 2013, 51:575-724.
86. Wood R.W., Grubman J., Weiss B. Nitrous oxide self-administration by the squirrel monkey. J. Pharmacol. Exp. Ther. 1977, 202:491-499.
87. Yang J.C., Clark W.C., Ngai S.H. Antagonism of nitrous oxide analgesia by naloxone in man. Anesthesiology 1980, 52:414-417.
88. Zacny J.P., Lichtor J.L., Coalson D.W., Apfelbaum J.L., Flemming D., Foster V. Time course of effects of brief inhalations of nitrous oxide in normal volunteers. Addiction 1994, 89:831-839.
89. Zacny J.P., Sparacino G., Hoffmann P., Martin R., Lichtor J.L. The subjective, behavioral and cognitive effects of subanesthetic concentrations of isoflurane and nitrous oxide in healthy volunteers. Psychopharmacol. Berl. 1994, 114:409-416.